MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 25 filers reported holding MYMD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $106 | -13.1% | 70,909 | 0.0% | 0.02% | +69.2% |
| Q1 2023 | $122 | +48.8% | 70,909 | 0.0% | 0.01% | +44.4% |
| Q4 2022 | $82 | -100.0% | 70,909 | 0.0% | 0.01% | -55.0% |
| Q3 2022 | $185,000 | +20.1% | 70,909 | 0.0% | 0.02% | +25.0% |
| Q2 2022 | $154,000 | -53.3% | 70,909 | 0.0% | 0.02% | -36.0% |
| Q1 2022 | $330,000 | -26.2% | 70,909 | 0.0% | 0.02% | -43.2% |
| Q2 2021 | $447,000 | – | 70,909 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Praetorian Wealth Management, Inc. | 200,000 | $118,400 | 0.04% |
| Atlas Brown,Inc. | 43,500 | $25,752 | 0.01% |
| Taylor & Morgan Wealth Management, LLC | 16,086 | $9,523 | 0.01% |
| Fidelis Capital Partners, LLC | 38,590 | $22,845 | 0.01% |
| Cambria Investment Management, L.P. | 171,570 | $101,569 | 0.01% |
| Corundum Group, Inc. | 19,600 | $11,603 | 0.01% |
| Bridgecreek Investment Management, LLC | 30,000 | $17,760 | 0.00% |
| XTX Topco Ltd | 39,544 | $23,410 | 0.00% |
| WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC | 14,000 | $8,288 | 0.00% |
| NWAM LLC | 40,000 | $23,680 | 0.00% |